(Total Views: 432)
Posted On: 01/25/2021 3:50:56 PM
Post# of 70
$DRRX News Article - DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study of DUR-928 in Severe Alcohol-Associated Hepatitis https://marketwirenews.com/news-releases/dure...72802.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
